Prodrug-based intracellular delivery of anticancer agents
- 13 January 2011
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 63 (1-2), 3-23
- https://doi.org/10.1016/j.addr.2010.12.005
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- Synthesis and In Vivo Antitumor Efficacy of PEGylated Poly(l-lysine) Dendrimer−Camptothecin ConjugatesMolecular Pharmaceutics, 2009
- Prodrug cancer gene therapyCancer Letters, 2008
- Endocytic mechanisms for targeted drug delivery☆Advanced Drug Delivery Reviews, 2007
- A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomasProceedings of the National Academy of Sciences, 2006
- Antibody-Drug Conjugates Designed to Eradicate Tumors with Homogeneous and Heterogeneous Expression of the Target AntigenCancer Research, 2006
- Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug deliveryMolecular BioSystems, 2005
- Dendrimers set to self-destructNature, 2003
- Effects of differentiation‐inducing agents on maturation of human MCF‐7 breast cancer cellsJournal of Cellular Physiology, 1990
- The biochemistry of lipoproteinsJournal of Inherited Metabolic Disease, 1988
- Phospholipid-nucleoside conjugates. 5. The interaction of selected 1-β-D-arabinofuranosylcytosine-5′-diphosphate-L-1,2-diacylglycerols with serum lipoproteinsBiochemical and Biophysical Research Communications, 1983